gavreto
roche registration gmbh - pralsetinib - carcinom, ikke-småcellet lunge - antineoplastiske midler - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.
metformin "accord" 1000 mg filmovertrukne tabletter
accord healthcare b.v. - metforminhydrochlorid - filmovertrukne tabletter - 1000 mg
metformin "accord" 850 mg filmovertrukne tabletter
accord healthcare b.v. - metforminhydrochlorid - filmovertrukne tabletter - 850 mg
metformin "zentiva" 1000 mg filmovertrukne tabletter
zentiva k.s. - metforminhydrochlorid - filmovertrukne tabletter - 1000 mg
metformin "zentiva" 850 mg filmovertrukne tabletter
zentiva k.s. - metforminhydrochlorid - filmovertrukne tabletter - 850 mg
metformin "laurus" 500 mg filmovertrukne tabletter
laurus generics gmbh - metforminhydrochlorid - filmovertrukne tabletter - 500 mg
metformin "teva b.v." 850 mg filmovertrukne tabletter
teva b.v. - metforminhydrochlorid - filmovertrukne tabletter - 850 mg
forminet 500 mg filmovertrukne tabletter
stada arzneimittel ag - metforminhydrochlorid - filmovertrukne tabletter - 500 mg